Clinical Trial Update: Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on an ongoing Phase 1/2 study evaluating the Magnetecs CGCI System for intracardiac mapping, with the current status listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Supraventricular Tachycardia
• Ventricular Tachycardia

Snippet

Sponsor: Magnetecs Corporation | Conditions: Tachycardia, Supraventricular, Tachycardia, Ventricular | Phase 1, Phase 2 | Status: UNKNOWN